Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Bradley Foster & Sargent Inc. CT

Bradley Foster & Sargent Inc. CT lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 41,908 shares of the medical equipment provider’s stock after buying an additional 719 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Intuitive Surgical were worth $21,874,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter worth $26,000. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the fourth quarter worth about $36,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter valued at approximately $38,000. Finally, DT Investment Partners LLC raised its position in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.3 %

NASDAQ ISRG opened at $606.57 on Friday. The stock has a market capitalization of $216.05 billion, a PE ratio of 94.63, a price-to-earnings-growth ratio of 5.87 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a 50 day moving average price of $564.41 and a two-hundred day moving average price of $523.46.

Analysts Set New Price Targets

A number of brokerages recently commented on ISRG. Wells Fargo & Company upped their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective on the stock. Bernstein Bank increased their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Finally, Evercore ISI increased their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.